Prospects for the worldwide control of colorectal cancer through screening

Gastrointestinal Endoscopy

Volumn 55, Issue 6, 2002, Pages 755-759

  Rozen, Paul ^a   Winawer, Sidney J ^b   Waye, Jerome D ^c  

^a OMED Colorectal Cancer Screening Committee   (Israel)

^b OMGE Committee on Digestive Cancers   (United States)

^c OMED/OMGE Education Committee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CANCER CONTROL; CANCER SCREENING; CHINA; COLONOSCOPY; COLORECTAL CANCER; CZECH REPUBLIC; EDITORIAL; EUROPEAN UNION; FRANCE; GERMANY; HEALTH PROGRAM; HEALTH PROMOTION; HIGH RISK POPULATION; ICELAND; ISRAEL; ITALY; JAPAN; OCCULT BLOOD; PRIORITY JOURNAL; SCANDINAVIA; SIGMOIDOSCOPE; SOUTH AND CENTRAL AMERICA; UNITED KINGDOM; UNITED STATES; WORLD HEALTH ORGANIZATION; COLORECTAL TUMOR; HUMAN; INTERNATIONAL COOPERATION; MASS SCREENING;

COLORECTAL NEOPLASMS; HUMANS; INTERNATIONAL COOPERATION; MASS SCREENING;

EID: 0036582976     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2002.123612     Document Type: Article

References (35)

1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: cancer incidence, mortality, and prevalence worldwide. Version 1.0. IARC Cancer Base No. 5. Lyon: IARC Press; 2001.
2. Rozen P, Young GP, Levin B, Spann SJ. Colorectal cancer in clinical practice: prevention, early detection and management. London: Martin Dunitz; 2002.
3. Santa M, Capocaccia R, Coleman MP, Berrino F, Gatta G, Micheli A, et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001;37:1659-67.
4. Rozen P. The OMED Colorectal Cancer Screening Committee: a report of its aims and activities. Gastrointest Endosc 1999;50:449-54.
5. Rozen P. Colorectal cancer: does early detection matter? Postgrad Med J 2001;77:289-91.
6. Rex D, Atkin W, Hoff G, Waye J. The flexible sigmoidoscope. Gastrointest Endosc 2000;52:587-9.
7. Winawer SJ, Crespi M, Zauber AG, Carlson MD, Rozen P. OMED/WHO/ASGE worldwide project for the prevention of colorectal cancer: international survey results (abstract). Gastrointest Endosc 2001;53:AB188.
8. Guidelines for the prevention, early detection and management of colorectal cancer. Available at: http://www.health.gov.au/nhmrc/publications/ synopses/cp62syn.htm. Accessed March 15, 2002.
9. Zhou DY, Feng FC, Pan DS, Lai ZS, Zhang WD, Zhang YL, et al. Comparative analysis of rectal mucus T antigen test with immunological fecal blood test in screening of colorectal cancer (Chinese). Chin J Digest 1993;13:315-6.
10. Zhou DY, Feng FC, Zhang YL, Lai ZS, Zhang WD, Li LB, et al. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects. Chin Med J 1993;106:739-42.
11. Liu XY, Zheng S, Zhang SZ, Ding XF, Shun YZ, Shun GH, et al. Reducing incidence and mortality from rectal cancer by polypectomy: a prospective study (Chinese). Chin J Epidemiol 2000;21:245-8.
12. Liu XY, Zheng S, Chen K, Ma XY, Zhou L, Yu H, et al. Randomized controlled trial of sequence mass screening program for colorectal cancer (Chinese). Chin J Epidemiol 2000;21:430-3.
13. Zavoral M, Ladmanová P, Friè P, Anto S F, Horák L, Ambruž L, et al. Colorectal cancer: guidelines for screening, diagnostics and treatment. Èeská a Slovenská gastroenterologie. (Czech) 2001;2:A11.
14. Fric P, Zavoral M, Dvorakova H, Zoubek V, Roth Z. An adapted program of colorectal cancer screening - 7 years experience and cost-benefit analysis. Hepatogastroenterology 1994;5:413-6.
15. Lynge E, Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European Union. Eur J Cancer 2000;36:1473-8.
16. Towler B, Irwig L, Glasziou P, Kewenter D, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. Brit Med J 1998;317:559-65.
17. Gnauck R. Screening for colon cancer in Germany. Tumori 1995;81:30-7.
18. Altenhofen L, Brenner C, Flatten G, Hofstadrer F, Kutz R, Oliveira J. Modellprojekt Früherkennung des kolorektalen Karzinoms. Deutscher Ärzte: Verlag, Köln; 1999.
19. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M; The Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-5.
20. Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res 1996;87:101-24.
21. Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995;61:465-9.
22. Saito H, Soma Y, Nakajima M, Koeda J, Kawaguchi H, Kakizaki R, et al. A case-control study evaluating occult blood screening for colorectal cancer with Hemoccult test and an immunochemical hemagglutination test. Oncol Reports 2000;7:815-8.
23. Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum 2000;43(Suppl):78-84.
24. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;48:1467-71.
25. Hoff G, Grotmol T, Bretthauer M, Gondal G, Hofstad B, Efskind P, et al. Flexible sigmoidoscopy screening: a randomised, controlled study of the population in the South of Norway. The Norwegian Colorectal Cancer Prevention study (NORCCAP) [abstract] Gastroenterology 2001;120(Suppl 1):A228.
26. Thiis-Evensen E, Hoff G, Sauar J, Langmark F, Majak BM, Vatn MH. Population based surveillance by colonoscopy. Effect on the incidence of colorectal cancer. Telemark polyp study No. 1. Scand J Gastroenterol 1999;34:414-20.
27. Hoff G, Thiis-Evensen E, Grotmol T, Sauar J, Vatn MH, Moen IE. Do unwanted effects of screening affect all cause mortality in flexible sigmoidoscopy screening programs? Eur J Cancer Prev 2001;10:31-7.
28. National Screening Committee. A summary of the colorectal cancer screening workshops and background papers. Available at: http://www.doh.gov.uk/ nsc/pdfs/summary. Accessed March 15, 2002.
29. Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, et al. Uptake, yield of neoplasia and adverse effects of flexible sigmoidoscopy Gut 1998;42:560-5.
30. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
31. Lieberman D, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfee G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study group 380. N Engl J Med 2000;343:162-8.
32. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-74.
33. Ahlquist DA, Skoletsky JE, Boynton KA, Harington JJ, Mahoney DW, Pierceall WE, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multi-target assay panel. Gastroenterology 2000;119:1219-27.
34. Winawer SJ, Stewart ES, Zauber AG, Bond JH, Ansel H, Waye JD, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 2000;342;1766-72.
35. Smith RA, Cokkinides V, von E, Levin B, Cohen C, Runowicz CD, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002;52:8-22.